β-blockers in heart failure: Clinical applications

JAMA

Volumn 287, Issue 7, 2002, Pages 890-897

  Farrell, Michael H ^a   Foody, Joanne Micale ^a   Krumholz, Harlan M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; AMNESIA; ARTICLE; ATRIOVENTRICULAR BLOCK; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; CONFUSION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EDEMA; FATIGUE; FEMALE; FLUID BALANCE; HEALTH CARE QUALITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART PALPITATION; HUMAN; HYPOTENSION; IMPOTENCE; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; VERTIGO;

EID: 0037138798     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.7.890     Document Type: Article

References (57)

1. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man
2. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle
3. β-Blocker therapy in heart failure: Scientific review
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
5. Effect of carvedilol on survival in severe chronic heart failure
6. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: US Carvedilol Heart Failure Study Group
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
8. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)
9. Beta-blockers in congestive heart failure: A Bayesian meta-analysis
10. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group
11. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: Pharmacological approaches
12. Guidelines for the diagnosis and treatment of chronic heart failure
13. Consensus recommendations for the management of chronic heart failure
14. Adjunctive drug therapy of acute myocardial infarction: Evidence from clinical trials
15. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study
16. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
17. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
18. A randomized trial of propranolol in patients with acute myocardial infarction, II: Morbidity results
19. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
20. Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or non-ischemic dilated cardiomyopathy
21. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: Results from the National Cooperative Cardiovascular Project
22. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma
23. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure
24. Experience of commencing carvedilol in elderly patients with heart failure in a routine outpatient clinic
25. National use and effectiveness of beta-blockers for the treatment of edlerly patients after acute myocardial infarction: National Cooperative Cardiovascular Project
26. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
27. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
28. Sex differences in the prognosis of congestive heart failure: Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II)
29. Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial
30. Preventable causative factors leading to hospital admission with decompensated heart failure
31. Early readmission of elderly patients with congestive heart failure
32. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
33. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
34. Beta-blockade in heart failure: A comparison of carvedilol with metoprolol
35. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger
36. COMET: A multicenter randomized double-blind study to compare the effect of carvedilol and metoprolol on mortality and morbidity in patients with moderate or severe congestive heart failure (NYHA II-IV)
37. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
38. Carvedilol produces dose-related improvements in left ventricular function and survival in patients with chronic heart failure
39. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
40. Heart failure disease management: A team approach
41. Heart failure disease management: A critical review
42. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice
43. Changing physician performance: A systematic review of the effect of continuing medical education strategies
44. Continuing education meetings and workshops: Effects on professional practice and health care outcomes (Cochrane Review)
45. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
46. Educational outreach visits: Effects on professional practice and health care outcomes
47. Local opinion leaders: Effects on professional practice and health care outcomes
48. Effects of computer-based clinical decision support systems on clinician performance and patient outcome: A critical appraisal of research
49. Improving preventive care by prompting physicians
50. Audit and feedback: Effects on professional practice and health care outcomes
51. Developing and testing changes in delivery of care